Our Work

The N=1 Collaborative is an international network of experts working together to bring individualized treatments to rare disease patients. We are initially focused on the use of antisense oligonucleotides (ASOs) as they are rapidly customizable. Through our efforts with ASOs, we are establishing a standardized framework for individualized medicine that will extend to other customizable platform technologies such as siRNAs, RNA therapeutics, and CRISPR as well.

 

Multidisciplinary collaboration was vital to making the earliest individualized medicines – milasen, jacifusen, and afinersen – possible. This collaborative ethos continues to be necessary in order to learn and improve.

 

Case Conferences & Seminar Series

The N1C Seminar Series will host leading experts in the field to advance important conversations in the personalized medicine space. We feature speakers from academia, industry, and people directly affected by rare disease. The format varies from research talks, to case conferences, to panel discussions. The talks are always open to the entire N1C community, with time allotted for Q&A. If you have ideas or requests for additional topics, please reach out to Erin McConnell at info@n1collaborative.org.

 

Workgroups

Special focus workgroups have been formed to address important topics critical to the development of individualized medicines. The current workgroups are listed below, with more to come.

Screen Shot 2022-11-15 at 12.21.33 PM.png

Patient Identification

We are developing and disseminating guidance on identifying patients that may be amenable to experimental individualized ASO intervention.

 

Watch the Workshop Recording

Screen Shot 2022-11-15 at 12.25.22 PM.png

Preclinical Design

We are promoting standards and advancing the science of ASO design and testing.

 

Watch the Workshop Recording

Flow Chart

Data Sharing

We are establishing databases to make sharing of preclinical and clinical learnings across individualized ASO treatments more efficient. By reducing the barriers to this type of sharing, we can learn and improve. ​

Screen Shot 2022-11-15 at 12.40.38 PM.png

Clinical Outcome Measures

We are developing unified approaches to capturing clinical outcome measures and safety signals.

 

Watch the Workshop Recording

Screen Shot 2022-11-15 at 12.35.25 PM.png

Institutional Implementation

We are sharing experiences and creating standardized templates and resources helpful to academic investigators and medical centers running individualized clinical trials.

 

Watch the Workshop Recording

Children in Science Class

Ethics & Equity

We are identifying and cataloging ethical, legal, and social issues that need to be addressed as we face this entirely new way of treating disease, as well as developing practical approaches for navigating them.